Your session is about to expire
β Back to Search
Stereotactic Body Radiation Therapy for Cancer
Study Summary
This trial is testing if radiation therapy can help recruit CD8 T cells to help with tumor control.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check βYesβ for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Side effects data
From 2022 Phase 2 trial β’ 29 Patients β’ NCT02045446Trial Design
Find a Location
Who is running the clinical trial?
Frequently Asked Questions
Are there any vacancies remaining for participants in this research trial?
"Affirmative. Clinicaltrials.gov has reported that this medical trial, which was initially published on June 20th 2022, is still recruiting patients. The research team requires 10 volunteers from a single clinic to participate in the study."
Are there any risks associated with Stereotactic Body Radiation Therapy for patients?
"The safety of Stereotactic Body Radiation Therapy is rated as a 1 since this experimental trial only has limited evidence for its efficacy and safety."
How many test subjects are receiving treatment in this experiment?
"Affirmative. According to the details on clinicaltrials.gov, this study is actively recruiting patients - with 10 individuals required from a single location - since it was first posted in June 2022 and revised last November."
Share this study with friends
Copy Link
Messenger